Europe

  • New GP chatbot integration offers early alcohol advice via Drinkaware partnership

    X-on Health, one of the UK’s leading providers of digital front door solutions for primary care, has announced a new partnership with Drinkaware, the UK’s leading alcohol charity. The collaboration will see signposting to Drinkaware’s evidence-based resources integrated directly into X-on Health’s AI Surgery Assist chatbot, used by GP surgeries across the whole of the [...]

  • AI could bring healthcare liability challenges, experts warn

    Artificial intelligence in healthcare could create complex legal challenges over who is responsible when medical failures occur, experts have warned. A new report raises concerns about who is accountable if patients are harmed by AI systems, along with issues such as limited effectiveness testing. The technology is being developed for clinical uses, including scan interpretation [...]

  • UK gov announces £50m mental health research boost

    The UK government has announced £50m in funding for mental health research that will place people with lived experience at the centre of developing new treatments. The Mental Health Goals programme aims to speed up the development of new medicines, technologies and therapies for conditions affecting one in four people in England. Poor mental health [...]

  • Roundup: Wearable patch reduces alcohol and drug cravings, and more

    Health Tech world explores the latest research developments in the world of health technology. New antibiotic targets IBD, and AI predicted how it would work Researchers have made two scientific breakthroughs at once: they have discovered a brand-new antibiotic that targets inflammatory bowel diseases (IBD), and have successfully used a new type of AI to [...]

  • Warburg Pincus to take significant minority stake in specialty diagnostics firm Sebia

    Warburg Pincus is set to acquire a significant minority stake in Sebia, a global provider of specialty diagnostics, in a deal expected to close no earlier than the first quarter of 2026. Terms of the transaction have not been disclosed.  Sebia, founded in 1967 and headquartered in Lisses, France, develops in vitro diagnostics systems used [...]

  • North London NHS Foundation Trust partners with Psyomics to transform mental health support for 1.6 million residents

    North London NHS Foundation Trust has signed a new partnership with leading digital health company Psyomics to revolutionise how people across Barnet, Camden, Enfield, Haringey, Islington access mental health care. The collaboration will see Psyomics’ digital technology rolled out across community services, enabling access to the right support more easily for over 1.6 million residents. [...]

  • Breakthrough as researchers uncover potential new Alzheimer’s treatment

    A potential new treatment target for Alzheimer's disease has been identified after a novel technique improved cognitive function in mice with the condition. Alzheimer's disease is thought to result from the abnormal build-up of proteins in and around brain cells. One of these proteins, amyloid, forms plaque around the cells. In an early study, researchers [...]

  • UK trial to assess AI effectiveness across all patient groups

    An east midlands NHS trust is carrying out the first UK evaluation of the safety and effectiveness of using AI software across different patient groups. University Hospitals of Leicester NHS Trust (UHL) is working with specialist AI evaluation company Aival to evaluate the performance of a system which currently supports clinicians when viewing chest X-rays. [...]

  • Men’s health startup Fellos secures €2 million funding

    Amsterdam-based online clinic Fellos has secured €2m in growth capital to expand its digital platform for men’s health services. The platform focuses on three areas where men often delay seeking help: sexual health conditions such as erectile dysfunction and premature ejaculation, skin conditions including acne, and hair loss. With the new funding, Fellos plans to [...]

  • UK and US regulators forge new collaboration on medtech and AI

    The UK's medicines regulator has announced plans to deepen collaboration with the US FDA to accelerate innovation, strengthen patient safety and reduce barriers to market access. Speaking at the Advanced Medical Technology Association (AdvaMed) conference in San Diego, Medicines and Healthcare products Regulatory Agency (MHRA) chief executive Lawrence Tallon outlined plans to align medical technology [...]